The Changing Definition and Perception of COPD

References

1. 1.↵
   1. Petty TL,
   2. Miercort R,
   3. Ryan S,
   4. Vincent T,
   5. Filley GF,
   6. Mitchell RS

   . The functional and bronchographic evaluation of postmortem human lungs. Am Rev Respir Dis 1965;92:450-458.

   OpenUrlPubMed
2. 2.↵
   1. Nett LM,
   2. Petty TL

   . Emphysema and chronic bronchitis defined. J Rehabil 1967;33(5):12.

   OpenUrlPubMed
3. 3.↵
   1. Petty TL

   . Definitions in chronic obstructive pulmonary disease. Clin Chest Med 1990;11(3):363-373.

   OpenUrlPubMed
4. 4.↵
   1. Petty TL

   . John Hutchinson's mysterious machine. Trans Am Clin Climatol Assoc 1987;98:11-20.

   OpenUrlPubMed
5. 5.
   1. Petty TL,
   2. Mannino DM

   . Will recommendations against spirometry make chronic obstructive pulmonary disease harder to treat? Ann Intern Med 2008;149(7):512-513; author reply 513.

   OpenUrlPubMed
6. 6.↵
   1. Petty TL

   . Commentary: quality of spirometry testing. Am J Med Qual 2001;16(6):216-218.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Petty TL

   . Risk factors in the development of chronic obstructive pulmonary disease. Med Sect Proc 1983:59-65.
8. 8.↵
   1. Petty TL

   . Clinical types of chronic obstructive pulmonary disease. Eur J Respir Dis Suppl 1986;146:329-335.

   OpenUrlPubMed
9. 9.↵
   1. Petty TL

   . COPD: clinical phenotypes. Pulm Pharmacol Ther 2002;15(4):341-351.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Petty TL

    . When cor pulmonale complicates the problem. Med Times 1978;106(1):34-38.

    OpenUrlPubMed
11. 11.↵
    1. Petty TL

    . Long-term out-patient oxygen therapy in advanced chronic obstructive pulmonary disease. Chest 1980;77(2 Suppl):304.

    OpenUrl
12. 12.↵
    1. Petty TL

    . Pharmacotherapy for chronic obstructive pulmonary disease. Postgrad Med 1986;80(2):56-66.

    OpenUrlPubMed
13. 13.↵
    1. Petty TL

    . Definition, epidemiology, course, and prognosis of COPD. Clin Cornerstone 2003;5(1):1-10.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Petty TL

    . Early diagnosis of COPD. Hosp Pract (1995) 2001;36(4):7-8.

    OpenUrl
15. 15.↵
    1. Ferguson GT,
    2. Petty TL

    . Screening and early intervention for COPD. Hosp Pract (1995) 1998;33(4):67-72.79-80, 83; discussion 83-64.

    OpenUrl
16. 16.↵
    1. Mannino DM,
    2. Buist AS,
    3. Petty TL,
    4. Enright PL,
    5. Redd SC

    . Lung function and mortality in the United States: data from the first National Health and Nutrition Examination Survey follow-up study. Thorax 2003;58(5):388-393.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Fletcher C

    . Terminology, definitions, and classification of chronic pulmonary emphysema and related conditions. A report of the conclusions of the CIBA Guest Symposium. Thorax 1959(14):286-299.
18. 18.↵
    1. Burrows B,
    2. Fletcher CM,
    3. Heard BE,
    4. Jones NL,
    5. Wootliff JS

    . The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago. Lancet 1966;1(7442):830-835.

    OpenUrlPubMedWeb of Science
19. 19.↵
    1. Fletcher C,
    2. Peto R

    . The natural history of chronic airflow obstruction. Br Med J 1977;1(6077):1645-1648.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987;136(1):225-244.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152(5 Pt 2):S77-S121.

    OpenUrlPubMed
22. 22.↵
    1. Pauwels RA,
    2. Buist AS,
    3. Ma P,
    4. Jenkins CR,
    5. Hurd SS,
    6. Committee GS

    . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 2001;46(8):798-825.

    OpenUrlPubMed
23. 23.↵
    1. Culver BH,
    2. Graham BL,
    3. Coates AL,
    4. Wanger J,
    5. Berry CE,
    6. Clarke PK,
    7. et al

    ; ATS Committee on Proficiency Standards for Pulmonary Function Laboratories. Recommendations for a Standardized pulmonary function report. An official American Thoracic Society technical statement. Am J Respir Crit Care Med 2017;196(11):1463-1472.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Celli BR,
    2. MacNee W

    ; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-946.

    OpenUrlFREE Full Text
25. 25.↵
    1. Vestbo J,
    2. Hurd SS,
    3. Rodriguez-Roisin R

    . The 2011 revision of the global strategy for the diagnosis, management, and prevention of COPD (GOLD) – why and what? Clin Respir J 2012;6(4):208-214.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Vogelmeier CF,
    2. Criner GJ,
    3. Martinez FJ,
    4. Anzueto A,
    5. Barnes PJ,
    6. Bourbeau J,
    7. et al

    . Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 Report. GOLD executive summary. Am J Respir Crit Care Med 2017;195(5):557-582.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Decramer M,
    2. Cooper CB

    . Treatment of COPD: the sooner the better? Thorax 2010;65(9):837-841.

    OpenUrlAbstract/FREE Full Text
28. 28.↵
    1. Lowe KE,
    2. Regan EA,
    3. Anzueto A,
    4. Austin E,
    5. Austin JHM,
    6. Beaty TH,
    7. et al

    . COPDGene 2019: redefining the diagnosis of chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis 2019;6(5):384-399.

    OpenUrlPubMed
29. 29.↵
    1. Han MK,
    2. Agusti A,
    3. Celli BR,
    4. Criner GJ,
    5. Halpin DMG,
    6. Roche N,
    7. et al

    . From GOLD 0 to Pre-COPD. Am J Respir Crit Care Med 2021;203(4):414-423.

    OpenUrlPubMed
30. 30.↵
    1. Thomashow BM,
    2. Mannino DM,
    3. Tal-Singer R,
    4. Crapo JD

    . A rapidly changing understanding of COPD: World COPD Day from the COPD Foundation. Am J Physiol Lung Cell Mol Physiol 2021;321(5):L983-L987.

    OpenUrl
31. 31.↵
    1. Ragland MF,
    2. Strand M,
    3. Baraghoshi D,
    4. Young KA,
    5. Kinney GL,
    6. Austin E,
    7. et al

    . 10-year follow-up of lung function, respiratory symptoms, and functional capacity in the COPDGene study. Ann Am Thorac Soc 2021.
32. 32.↵
    1. Alabi FO,
    2. Alkhateeb HA,
    3. DeBarros KM,
    4. Barletti Benel PS,
    5. Sanchez-Martez RL,
    6. Zeper ML,
    7. et al

    . The heterogeneity of COPD patients in a community-based practice and the inadequacy of the Global Initiative for Chronic Obstructive Lung Disease Criteria: a real-world experience. Chronic Obstr Pulm Dis 2021;8(3):396-407.

    OpenUrl
33. 33.↵
    1. Quanjer PH,
    2. Stanojevic S,
    3. Cole TJ,
    4. Baur X,
    5. Hall GL,
    6. Culver BH,
    7. et al

    ; ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3–95 y age range: the global lung function 2012 equations. Eur Respir J 2012;40(6):1324-1343.

    OpenUrlAbstract/FREE Full Text
34. 34.↵
    GOLD Scientific Committee. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Available at: https://goldcopd.org/2022-gold-reports-2/. Accessed May 5, 2022.
35. 35.↵
    1. Milne S,
    2. Sin DD

    . Biomarkers in chronic obstructive pulmonary disease: the gateway to precision medicine. Clin Chest Med 2020;41(3):383-394.

    OpenUrl
36. 36.↵
    1. Agusti A,
    2. Bel E,
    3. Thomas M,
    4. Vogelmeier C,
    5. Brusselle G,
    6. Holgate S,
    7. et al

    . Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J 2016;47(2):410-419.

    OpenUrlAbstract/FREE Full Text
37. 37.↵
    1. Gupta P,
    2. Wen H,
    3. Di Francesco L,
    4. Ayazi F

    . Detection of pathological mechano-acoustic signatures using precision accelerometer contact microphones in patients with pulmonary disorders. Sci Rep 2021;11(1):13427.

    OpenUrl